↓ Skip to main content

Dove Medical Press

Clickable prodrugs bearing potent and hydrolytically cleavable nicotinamide phosphoribosyltransferase inhibitors

Overview of attention for article published in Drug Design, Development and Therapy, April 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
13 Mendeley
Title
Clickable prodrugs bearing potent and hydrolytically cleavable nicotinamide phosphoribosyltransferase inhibitors
Published in
Drug Design, Development and Therapy, April 2018
DOI 10.2147/dddt.s152685
Pubmed ID
Authors

Keivan Sadrerafi, Emilia O Mason, Mark W Lee

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 15%
Researcher 2 15%
Student > Bachelor 1 8%
Other 1 8%
Student > Master 1 8%
Other 1 8%
Unknown 5 38%
Readers by discipline Count As %
Chemistry 3 23%
Medicine and Dentistry 2 15%
Immunology and Microbiology 1 8%
Biochemistry, Genetics and Molecular Biology 1 8%
Unknown 6 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2024.
All research outputs
#8,628,139
of 25,608,265 outputs
Outputs from Drug Design, Development and Therapy
#653
of 2,271 outputs
Outputs of similar age
#139,519
of 344,401 outputs
Outputs of similar age from Drug Design, Development and Therapy
#15
of 63 outputs
Altmetric has tracked 25,608,265 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,271 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,401 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.